Evolution of our view on the IgE molecule role in bronchial asthma and the clinical effect of its modulation by omalizumab: Where do we stand today?

International Journal of Immunopathology and Pharmacology
Jakub Novosad, Irena Krčmová

Abstract

Bronchial asthma is a heterogeneous disease whose definition and treatment are based on evidence of variable airway obstruction and airway inflammation. Despite the enormous increase in the amount of information on the pathogenesis of this disease, diagnosis is still an unresolved problem, as we still lack sensitive and specific biomarkers. On the other hand, at the turn of the 20th and 21st century, there was a rapid development of therapeutic modalities based on the principle of biological therapy. The first authorized drug matching these characteristics was omalizumab - a monoclonal antibody directed against immunoglobulin E (IgE). It has been used for the treatment of severe forms of bronchial asthma for more than 15 years, which is a sufficient time to acquire ways of its effective use and to assess whether the treatment with omalizumab has met our expectations. However, we continue to discover new and surprising facts about the effects of omalizumab treatment which leads to widening of therapeutic indications. In this work, a basic overview of the very complex role of the IgE molecule in the organism (with a special emphasis on allergic asthma) is discussed, and the most important practical and clinical consequences resul...Continue Reading

References

Feb 2, 1989·The New England Journal of Medicine·B BurrowsM G Cline
Feb 1, 1988·Immunological Reviews·C M SnapperW E Paul
Mar 1, 1985·European Journal of Immunology·J S Marshall, E B Bell
May 1, 1997·International Archives of Allergy and Immunology·G Stingl, D Maurer
Jan 6, 1999·Cell·S C GarmanT S Jardetzky
Feb 11, 2000·The Journal of Allergy and Clinical Immunology·L B Bacharier, R S Geha
May 22, 2001·British Medical Bulletin·B J SuttonA J Beavil
Aug 10, 2001·The Journal of Allergy and Clinical Immunology·W BusseN Gupta
Sep 1, 2001·The European Respiratory Journal·M SolèrG Della Cioppa
Aug 9, 2002·The European Respiratory Journal·R BuhlG Della Cioppa
Apr 3, 2003·European Journal of Immunology·Sophia N KaragiannisHannah J Gould
Dec 6, 2003·The Journal of Allergy and Clinical Immunology·Barbara FosterCalman Prussin
Jul 15, 2006·Chest·Sidney S Braman
Mar 6, 2007·The Journal of Allergy and Clinical Immunology·Taku Kambayashi, Gary A Koretzky
Mar 31, 2007·Nature Reviews. Drug Discovery·Roy PettipherRichard Armer
May 2, 2007·The European Respiratory Journal·P Bradding
Oct 30, 2007·Allergology International : Official Journal of the Japanese Society of Allergology·Etsuko Tagaya, Jun Tamaoki
Feb 28, 2008·Nature Reviews. Immunology·Hannah J Gould, Brian J Sutton
Dec 10, 2009·Current Opinion in Allergy and Clinical Immunology·John D Colgan, Isaiah L Hankel
Mar 5, 2010·The Journal of Allergy and Clinical Immunology·Kelly D StoneDean D Metcalfe
Feb 11, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Senthilkumar PalaniyandiXiaoping Zhu
Mar 12, 2011·British Journal of Clinical Pharmacology·Philip J Lowe, Didier Renard
Jul 15, 2011·The Journal of Allergy and Clinical Immunology·Sheharyar R DurraniWilliam W Busse
Aug 5, 2011·The New England Journal of Medicine·Jonathan CorrenJohn G Matthews
Jan 13, 2012·Respiration; International Review of Thoracic Diseases·Makoto Hoshino, Junichi Ohtawa
Jan 24, 2012·American Journal of Respiratory and Critical Care Medicine·Kelly Wong McGrathUNKNOWN Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute
May 15, 2012·Pulmonary Pharmacology & Therapeutics·Naresh Singh Redhu, Abdelilah S Gounni
Oct 2, 2012·The Journal of Allergy and Clinical Immunology·Philippe GevaertClaus Bachert
Mar 23, 2013·The European Respiratory Journal·Antoine DeschildreJocelyne Just
Aug 8, 2013·Nature Medicine·Guy G BrusselleKen R Bracke
Sep 6, 2013·Clinical and Translational Allergy·Marcia A ChanLanny J Rosenwasser
Dec 18, 2013·The European Respiratory Journal·Kian Fan ChungW Gerald Teague

❮ Previous
Next ❯

Citations

Dec 17, 2020·International Journal of Molecular Sciences·Annina LylySanna Toppila-Salmi

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT03280550
NCT03280537
NCT03478930

Software Mentioned

XPORT
PERSIST
eXpeRience

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Related Papers

The New England Journal of Medicine
David E WinchesterTom Murphy
The New England Journal of Medicine
André-Bernard Tonnel, Isabelle Tillie-Leblond
The New England Journal of Medicine
Robert C Strunk, Gordon R Bloomberg
Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine
Neil C Thomson, Rekha Chaudhuri
© 2021 Meta ULC. All rights reserved